Cargando…

Immunotherapy for Gastric Cancer: Time for a Personalized Approach?

Over the last decade, our understanding of the mechanisms underlying immune modulation has greatly improved, allowing for the development of multiple therapeutic approaches that are revolutionizing the treatment of cancer. Immunotherapy for gastric cancer (GC) is still in the early phases but is rap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dolcetti, Riccardo, De Re, Valli, Canzonieri, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032163/ https://www.ncbi.nlm.nih.gov/pubmed/29844297 http://dx.doi.org/10.3390/ijms19061602

Ejemplares similares

Proposed Molecular and miRNA Classification of Gastric Cancer
por: Alessandrini, Lara, et al.
Publicado: (2018)

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

Endomicroscopy and Cancer: A New Approach to the Visualization of Neoangiogenesis
por: Cannizzaro, Renato, et al.
Publicado: (2012)

A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area
por: De Re, Valli, et al.
Publicado: (2023)

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma
por: Repetto, Ombretta, et al.
Publicado: (2018)

Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
por: De Re, Valli, et al.
Publicado: (2017)

Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis
por: Fornasarig, Mara, et al.
Publicado: (2018)

Differential Helicobacter pylori Plasticity in the Gastric Niche of Subjects at Increased Gastric Cancer Risk
por: Casarotto, Mariateresa, et al.
Publicado: (2019)

MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
por: De Re, Valli, et al.
Publicado: (2009)

Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020)

Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer
por: Garziera, Marica, et al.
Publicado: (2013)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
por: Kim, Moonsik, et al.
Publicado: (2023)

Molecular Features Distinguish Gastric Cancer Subtypes
por: De Re, Valli
Publicado: (2018)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype
por: Caggiari, Laura, et al.
Publicado: (2017)

Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?
por: Chew, Hui Yi, et al.
Publicado: (2020)

Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors
por: Magris, Raffaella, et al.
Publicado: (2020)

Immunotherapy in Gastric Cancer
por: Högner, Anica, et al.
Publicado: (2022)

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2019)

Two-dimensional gel proteome reference map of human small intestine
por: Simula, Maria Paola, et al.
Publicado: (2009)

Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers
por: Miolo, GianMaria, et al.
Publicado: (2009)

Chemotherapy for gastric cancer patients – time for personalization in medicine?
por: Nowara, Elżbieta, et al.
Publicado: (2012)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Updated Immunotherapy for Gastric Cancer
por: Narita, Yukiya, et al.
Publicado: (2023)

Neo‐Antigen‐Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach
por: Chen, Guan‐Liang, et al.
Publicado: (2023)

KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer
por: Muraro, Elena, et al.
Publicado: (2022)

HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma
por: De Re, Valli, et al.
Publicado: (2022)

Novel Biomarkers for Personalized Cancer Immunotherapy
por: Shindo, Yoshitaro, et al.
Publicado: (2019)

Personalized immunotherapy in cancer precision medicine
por: Kiyotani, Kazuma, et al.
Publicado: (2021)

Ovarian Cancer Immunotherapy and Personalized Medicine
por: Morand, Susan, et al.
Publicado: (2021)

Use of immunotherapy in the treatment of gastric cancer
por: Yang, Luhong, et al.
Publicado: (2019)

The New Era of Immunotherapy in Gastric Cancer
por: Takei, Shogo, et al.
Publicado: (2022)

Research Progress of Immunotherapy for Gastric Cancer
por: Zhang, Zhipeng, et al.
Publicado: (2023)

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2018)

Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street Approach
por: Versluis, Judith M, et al.
Publicado: (2020)

Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer
por: Repetto, Ombretta, et al.
Publicado: (2021)

Personalized Nutrition Approach in Food Allergy: Is It Prime Time Yet?
por: D’Auria, Enza, et al.
Publicado: (2019)

Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach
por: Coleman, Niamh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pgtq5fdthae4dq9kod778m10k8